End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 NZD | +0.70% | +0.94% | -2.71% |
Mar. 13 | Vital Healthcare Property Trust Declares DRP Strike Price for Q2 Dividend | MT |
Feb. 15 | Vital Healthcare Property Trust Widens Net Loss in Fiscal H1 | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company appears to be poorly valued given its net asset value.
- The company is one of the best yield companies with high dividend expectations.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Most analysts recommend that the stock should be sold or reduced.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.71% | 851M | D+ | ||
+6.23% | 57.45B | A- | ||
-6.12% | 18.62B | A- | ||
-4.19% | 13.49B | A | ||
+2.22% | 7.72B | B | ||
-15.50% | 5.55B | B- | ||
+11.57% | 3.42B | C- | ||
+0.56% | 3.29B | C+ | ||
-1.49% | 3.16B | B+ | ||
+15.88% | 2.8B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- VHP Stock
- Ratings Vital Healthcare Property Trust